Clinical trial
A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical…
NCT00427050 · Peplin, Industry · Completed
Key facts
| NCT number | NCT00427050 |
|---|---|
| Title | A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel |
| Official title | An Open-label, Multi-centre, Dose-escalation, Cohort Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel When Applied to a 25 cm2 Contiguous Actinic Keratoses Treatment Area on the Face or Face and Scalp. |
| Lead sponsor | Peplin, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Actinic Keratoses |
| Intervention type | Drug |
| Interventions | PEP005 |
| Enrollment | 50 |
| Start date | Jan 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jan 26, 2007 |
| Last update posted | Sep 14, 2015 |
| Countries | Australia, New Zealand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: